Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest FP7 Stories

2013-12-03 12:26:46

MONT-SAINT-GUIBERT, Belgium, December 3, 2013 /PRNewswire/ -- Cardio3 BioSciences SA (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, and member of a research consortium under the 7th Framework Programme (FP7) of the European Commission's Research and Innovation today announces that it has obtained a second FP7 grant ; EUR6.8m for a project...

2013-11-25 08:26:17

MONT-SAINT-GUIBERT, Belgium, November 25, 2013 /PRNewswire/ -- Cardio3 BioSciences SA (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, today announces it is part of a consortium which has been awarded a highly competitive European Union Seventh Framework Programme for Research and Innovation (FP7) research grant from the European Union to...

2013-09-24 04:22:03

STOCKHOLM, September 24, 2013 /PRNewswire/ -- OxThera AB announces today that it is the coordinator of a new EU-project, Elimox, that will run for 2 years and has been provided an FP7 grant of EUR2.19 million. The primary aim of the project is to develop an innovative and unique bacterial pharmaceutical product for the treatment of a severe and debilitating inherited disease; Primary Hyperoxaluria (PH). "We are extremely happy to get this contribution for the...

2013-04-23 08:32:52

LUXEMBOURG, April 23, 2013 /PRNewswire/ -- Creabilis SA, a late clinical stage European biotechnology company specialising in the development of treatments in dermatology, for inflammation and pain, today announces that it has been awarded a prestigious European Union Framework Programme 7 (FP7) grant in the 'Health: Systems Medicine' work programme theme. The EUR1.98m FP7 grant will be used to develop the next generation of Creabilis' 'topical-by-design' pre-clinical candidates...

2013-04-18 21:31:22

The European Commission needs to make some key innovations in its science funding program if Europe is to enjoy the full benefits of the 70 billion to be spent on science research as part of the Horizon 2020 program kicking off in 2014, according to an academic paper published by SAGE in the Journal of Health Services Research & Policy today. The Commission has already taken important steps to reduce administration costs and stimulate the participation of small business in research,...

2013-04-18 12:30:18

The European Commission needs to make some key innovations in its science funding program if Europe is to enjoy the full benefits of the 70 billion to be spent on science research as part of the Horizon 2020 program kicking off in 2014, according to an academic paper published by SAGE in the Journal of Health Services Research & Policy today. The Commission has already taken important steps to reduce administration costs and stimulate the participation of small business in research,...